Literature DB >> 1112457

Biliary excretion of iodipamide.

P M Loeb, R N Berk, G K Feld, H O Wheeler.   

Abstract

Conflicting data have been reported concerning the optimum dose and rate of administration of iodipamide required to obtain maximum radiographic opacification of the biliary tree during intravenous cholangiography. Experiments were performed in dogs to determine the effect of plasma concentration on the excretion and concentration of iodipamide in the bile and urine during a steady state of infusion and excretion. The data indicate that a hyperbolic relation exists between the plasma concentration and both the biliary concentration and the total biliary excretion. A mathematical expression of these relations is presented. At low plasma concentrations, iodipamide was not excreted in the urine. However, at high plasma concentrations, urinary excretion increased sharply. It appears that a biliary concentration of iodipamide sufficient to achieve adequate radiographic visualization of the biliary tree can be obtained without significant renal excretion by constant infusion of iodipamide at an appropriate rate in dogs. Stepwise increase in the infusion rate until adequate radiographic visualization is obtained may be the best method for performing intravenous cholangiography to obtain visualization with the least amount of iodipamide in order to minimize toxicity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112457

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Iotroxamide studies in man--plasma binding, renal and biliary excretion studies in jaundiced and anicteric patients.

Authors:  J Doran; W Vennart; C R Richmond; G D Bell
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

2.  Consideration of hepatic factor influence on drip infusion cholangiography.

Authors:  T Namihisa; M Nambu; T Kon; K Iijima
Journal:  Gastroenterol Jpn       Date:  1976

3.  Common properties of hepatocellular uptake of cholate, iodipamide and antamanide, as distinct from the uptake of bromosulfophthalein.

Authors:  E Petzinger; C Joppen; M Frimmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.